MX2022013006A - Inhibidor de bcl-2. - Google Patents
Inhibidor de bcl-2.Info
- Publication number
- MX2022013006A MX2022013006A MX2022013006A MX2022013006A MX2022013006A MX 2022013006 A MX2022013006 A MX 2022013006A MX 2022013006 A MX2022013006 A MX 2022013006A MX 2022013006 A MX2022013006 A MX 2022013006A MX 2022013006 A MX2022013006 A MX 2022013006A
- Authority
- MX
- Mexico
- Prior art keywords
- bcl
- inhibitor
- compound
- disclosed
- inhibiting
- Prior art date
Links
- 239000012664 BCL-2-inhibitor Substances 0.000 title 1
- 229940123711 Bcl2 inhibitor Drugs 0.000 title 1
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 abstract 3
- 101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000001640 apoptogenic effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
En la presente se describe un compuesto de la Fórmula (I) para inhibir tanto Bcl-2 de tipo silvestre como Bcl-2 mutado, en particular, Bcl-2 G101V y D103Y, y un método para usar el compuesto divulgado en la presente para el tratamiento contra enfermedades apoptóticas no reguladas.
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2020084992 | 2020-04-15 | ||
| CN2020100472 | 2020-07-06 | ||
| CN2020125580 | 2020-10-30 | ||
| CN2021075831 | 2021-02-07 | ||
| CN2021086189 | 2021-04-09 | ||
| PCT/CN2021/087225 WO2021208963A1 (en) | 2020-04-15 | 2021-04-14 | Bcl-2 inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022013006A true MX2022013006A (es) | 2023-01-11 |
Family
ID=78083530
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022013006A MX2022013006A (es) | 2020-04-15 | 2021-04-14 | Inhibidor de bcl-2. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230159522A1 (es) |
| EP (1) | EP4136084A4 (es) |
| JP (1) | JP2023520843A (es) |
| KR (1) | KR20230002419A (es) |
| CN (3) | CN116969936A (es) |
| AU (1) | AU2021256580A1 (es) |
| BR (1) | BR112022019525A2 (es) |
| CA (1) | CA3172478A1 (es) |
| IL (1) | IL296582A (es) |
| MX (1) | MX2022013006A (es) |
| TW (1) | TW202200574A (es) |
| WO (1) | WO2021208963A1 (es) |
| ZA (1) | ZA202209891B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022213335A1 (en) * | 2021-04-09 | 2022-10-13 | Beigene (Beijing) Co., Ltd. | Method for preparing intermediate of bcl-2 inhibitor |
| WO2023078398A1 (en) * | 2021-11-05 | 2023-05-11 | Fochon Pharmaceuticals, Ltd. | Compounds as bcl-2 inhibitors |
| AU2022394660A1 (en) * | 2021-11-20 | 2024-06-06 | Fochon Biosciences, Ltd. | Compounds as bcl-2 inhibitors |
| WO2023104043A1 (zh) | 2021-12-06 | 2023-06-15 | 杭州和正医药有限公司 | 一种抗凋亡蛋白bcl-2抑制剂、药物组合物及其应用 |
| WO2023122000A1 (en) * | 2021-12-20 | 2023-06-29 | Newave Pharmaceutical Inc. | Bcl-2 inhibitors |
| CN114292192A (zh) * | 2022-01-17 | 2022-04-08 | 山东泓瑞医药科技股份公司 | 一种3,4-二甲氧基苯甲酸甲酯的合成方法 |
| WO2023178035A1 (en) | 2022-03-14 | 2023-09-21 | Slap Pharmaceuticals Llc | Multicyclic compounds |
| WO2023231777A1 (en) * | 2022-06-01 | 2023-12-07 | Fochon Pharmaceuticals, Ltd. | Compounds as bcl-2 inhibitors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106749233B (zh) * | 2016-11-24 | 2020-04-21 | 中山大学 | 一类磺酰胺衍生物及其应用 |
| CN108002087B (zh) * | 2017-01-03 | 2019-05-10 | 东莞理工学院 | 一种多种宽度规格的新旧smt接料带的粘接机 |
| US11420968B2 (en) * | 2018-04-29 | 2022-08-23 | Beigene, Ltd. | Bcl-2 inhibitors |
| WO2020140005A2 (en) * | 2018-12-29 | 2020-07-02 | Newave Pharmaceutical Inc. | Bcl-2 inhibitors |
| WO2022213335A1 (en) * | 2021-04-09 | 2022-10-13 | Beigene (Beijing) Co., Ltd. | Method for preparing intermediate of bcl-2 inhibitor |
-
2021
- 2021-04-14 JP JP2022554627A patent/JP2023520843A/ja active Pending
- 2021-04-14 AU AU2021256580A patent/AU2021256580A1/en active Pending
- 2021-04-14 EP EP21789482.3A patent/EP4136084A4/en active Pending
- 2021-04-14 IL IL296582A patent/IL296582A/en unknown
- 2021-04-14 CN CN202310559385.4A patent/CN116969936A/zh active Pending
- 2021-04-14 US US17/916,845 patent/US20230159522A1/en active Pending
- 2021-04-14 KR KR1020227035815A patent/KR20230002419A/ko active Search and Examination
- 2021-04-14 WO PCT/CN2021/087225 patent/WO2021208963A1/en active Application Filing
- 2021-04-14 MX MX2022013006A patent/MX2022013006A/es unknown
- 2021-04-14 CA CA3172478A patent/CA3172478A1/en active Pending
- 2021-04-14 CN CN202310560508.6A patent/CN116969937A/zh active Pending
- 2021-04-14 CN CN202180029718.1A patent/CN116802179A/zh active Pending
- 2021-04-14 TW TW110113455A patent/TW202200574A/zh unknown
- 2021-04-14 BR BR112022019525A patent/BR112022019525A2/pt unknown
-
2022
- 2022-09-05 ZA ZA2022/09891A patent/ZA202209891B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021208963A1 (en) | 2021-10-21 |
| BR112022019525A2 (pt) | 2023-11-14 |
| CA3172478A1 (en) | 2021-10-21 |
| CN116802179A (zh) | 2023-09-22 |
| TW202200574A (zh) | 2022-01-01 |
| CN116969936A (zh) | 2023-10-31 |
| IL296582A (en) | 2022-11-01 |
| AU2021256580A1 (en) | 2022-09-29 |
| CN116969937A (zh) | 2023-10-31 |
| ZA202209891B (en) | 2023-05-31 |
| US20230159522A1 (en) | 2023-05-25 |
| EP4136084A1 (en) | 2023-02-22 |
| JP2023520843A (ja) | 2023-05-22 |
| EP4136084A4 (en) | 2023-11-01 |
| KR20230002419A (ko) | 2023-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022013006A (es) | Inhibidor de bcl-2. | |
| MX2023001689A (es) | Inhibidores de bcl-2. | |
| EA200800006A1 (ru) | Триазолопиридины в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы типа i | |
| MX2023012726A (es) | Compuestos heterociclicos y metodos de uso. | |
| MX2024001893A (es) | Compuestos heterociclicos y metodos de uso. | |
| MX2024001894A (es) | Compuestos heterociclicos y metodos de uso. | |
| CR20230362A (es) | Inhibidores de cdk2 y métodos de uso de los mismos | |
| MX2024001824A (es) | Compuestos heterociclicos y metodos de uso. | |
| MY138732A (en) | Conjugated complement cascade inhibitors | |
| AU2483000A (en) | Treatment of asthma with mek inhibitors | |
| MX2022013081A (es) | Compuestos para el tratamiento de sars. | |
| MX2022001004A (es) | Inhibidores de enzimas. | |
| MX2024000271A (es) | Inhibidor de shp2 y uso del mismo. | |
| WO2022119858A8 (en) | Compounds for the treatment of sars | |
| MX2024001774A (es) | Compuesto inductor de la degradacion de plk1 novedoso. | |
| MX2022009197A (es) | Metodos de tratamiento para deficiencia de alfa-1 antitripsina. | |
| ZA202212095B (en) | Il4i1 inhibitors and methods of use | |
| WO2024026479A3 (en) | Cdk2 inhibitors and methods of using the same | |
| WO2024026483A3 (en) | Cdk2 inhibitors and methods of using the same | |
| WO2024026484A3 (en) | Cdk2 inhibitors and methods of using the same | |
| MX2022014303A (es) | Compuestos para el tratamiento del sars. | |
| MX2022002446A (es) | Compuestos de pirrolopirimidina inhibidores de perk. | |
| WO2024026486A3 (en) | Cdk2 inhibitors and methods of using the same | |
| MX2022000545A (es) | Inhibidores de enzimas. | |
| WO2019195641A3 (en) | 1,3,4-oxadiazoles as inhibitors of rho/mrtf/srf-mediated gene transcription and methods for use of the same |